Laurel Wealth Advisors (California)’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$341K Buy
2,166
+48
+2% +$7.3K 0.03% 463
2022
Q3
$319K Buy
2,118
+742
+54% +$123K 0.03% 468
2022
Q2
$226K Sell
1,376
-618
-31% -$119K 0.02% 594
2022
Q1
$444K Buy
1,994
+55
+3% +$12.3K 0.04% 445
2021
Q4
$460K Buy
+1,939
New +$453K 0.04% 476

Other funds holding ICUI

Laurel Wealth Advisors (California)'s ICUI Position: Q4 2022 in Review

Laurel Wealth Advisors (California) increased its ICU Medical (ICUI) stake by 2.3% in Q4 2022, buying an estimated $7.3K and bringing the position to 2,166 shares worth $341K. The position accounts for 0.03% of the portfolio, ranked #463.

Laurel Wealth Advisors (California) first reported a position in ICUI in Q4 2021 and has held it in 5 quarters since. The position peaked at $460K in Q4 2021. 247 funds tracked by Wall St. Rank hold ICUI as of Q4 2022.

  • Laurel Wealth Advisors (California) held 2,166 shares of ICU Medical worth $341K as of Q4 2022.
  • Laurel Wealth Advisors (California) bought 48 ICU Medical shares in Q4 2022, an estimated $7.3K.
  • ICU Medical made up 0.03% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #463 holding.
  • Laurel Wealth Advisors (California) first reported a position in ICU Medical in Q4 2021 and has held it in 5 quarters since.
  • Laurel Wealth Advisors (California)'s ICU Medical position peaked at $460K in Q4 2021.
  • 247 funds tracked by Wall St. Rank held ICU Medical as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.